These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 21056868

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
    Shelly J, Uhlmann A, Sinclair H, Howells FM, Sibeko G, Wilson D, Stein DJ, Temmingh H.
    Psychopathology; 2016; 49(6):429-435. PubMed ID: 27926911
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Willi TS, Lang DJ, Honer WG, Smith GN, Thornton AE, Panenka WJ, Procyshyn RM, Vila-Rodriguez F, Su W, Vertinsky AT, Leonova O, Rauscher A, MacEwan GW, Barr AM.
    Schizophr Res; 2016 Oct; 176(2-3):158-163. PubMed ID: 27499362
    [Abstract] [Full Text] [Related]

  • 29. How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data.
    McKetin R, Clare PJ, Castle D, Turner A, Kelly PJ, Lubman DI, Arunogiri S, Manning V, Berk M.
    Addiction; 2023 Oct; 118(10):1975-1983. PubMed ID: 37157055
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R, Hides L, Kavanagh DJ, Saunders JB, Dawe S.
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
    Srisurapanont M, Arunpongpaisal S, Wada K, Marsden J, Ali R, Kongsakon R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):959-64. PubMed ID: 21277930
    [Abstract] [Full Text] [Related]

  • 37. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R, Fassbender C, Iosif AM, Ursu S, Leamon MH, Carter C.
    Psychiatry Res; 2013 Dec 15; 210(2):529-35. PubMed ID: 23896355
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia.
    Wang LJ, Lin SK, Chen YC, Huang MC, Chen TT, Ree SC, Chen CK.
    Psychopathology; 2016 Dec 15; 49(2):108-15. PubMed ID: 27071042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.